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Niemann-Pick C1 protects against
atherosclerosis in mice via regulation
of macrophage intracellular
cholesterol trafficking
Jessie R. Zhang,1 Trey Coleman,1 S. Joshua Langmade,1 David E. Scherrer,1
Lindsay Lane,1 M. Hunter Lanier,1 Chu Feng,1 Mark S. Sands,1,2 Jean E. Schaffer,1,3
Clay F. Semenkovich,1,4 and Daniel S. Ory1,4
1Department

of Medicine, 2Department of Genetics, 3Department of Molecular Biology and Pharmacology, and 4Department of Cell Biology and Physiology,
Washington University School of Medicine, St. Louis, Missouri, USA.

Niemann-Pick C1 (NPC1) is a key participant in cellular cholesterol trafficking. Loss of NPC1 function leads
to defective suppression of SREBP-dependent gene expression and failure to appropriately activate liver X
receptor–mediated (LXR-mediated) pathways, ultimately resulting in intracellular cholesterol accumulation.
To determine whether NPC1 contributes to regulation of macrophage sterol homeostasis in vivo, we examined
the effect of NPC1 deletion in BM-derived cells on atherosclerotic lesion development in the Ldlr–/– mouse
model of atherosclerosis. High-fat diet–fed chimeric Npc1–/– mice reconstituted with Ldlr–/–Npc1–/– macrophages exhibited accelerated atherosclerosis despite lower serum cholesterol compared with mice reconstituted with wild-type macrophages. The discordance between the low serum lipoprotein levels and the presence
of aortic atherosclerosis suggested that intrinsic alterations in macrophage sterol metabolism in the chimeric
Npc1–/– mice played a greater role in atherosclerotic lesion formation than did serum lipoprotein levels. Macrophages from chimeric Npc1–/– mice showed decreased synthesis of 27-hydroxycholesterol (27-HC), an endogenous LXR ligand; decreased expression of LXR-regulated cholesterol transporters; and impaired cholesterol
efflux. Lower 27-HC levels were associated with elevated cholesterol oxidation products in macrophages and
plasma of chimeric Npc1–/– mice and with increased oxidative stress. Our results demonstrate that NPC1 serves
an atheroprotective role in mice through regulation of LXR-dependent cholesterol efflux and mitigation of
cholesterol-induced oxidative stress in macrophages.
Introduction
Macrophages regulate tissue lipid homeostasis through the
uptake and catabolism of atherogenic plasma lipoproteins (1).
Macrophages express scavenger receptor A and CD36, which
bind and internalize modified lipoproteins, such as oxidized
LDL. Upon internalization, lipoprotein-derived cholesterol is
delivered to a late endosomal organelle, where cholesterol esters
are hydrolyzed to free cholesterol. Delivery of free cholesterol
from the endocytic pathway to the plasma membrane and ER
requires the coordinated actions of the late endosomal Niemann-Pick C1 (NPC1) and lysosomal NPC2 proteins (2). Delivery of cholesterol to the ER rapidly stimulates esterification
and accumulation of cholesterol ester in cytoplasmic droplets.
Because the scavenger receptors, in contrast to the LDL receptor (LDLR), are not controlled by a sterol-regulated negative
feedback loop, macrophages accumulate massive quantities of
lipoprotein-derived lipids.
Nonstandard abbreviations used: AcLDL, acetylated LDL; BMT, BM transplant; GC/MS, gas chromatography/mass spectrometry; HC, hydroxycholesterol;
H2DCFDA, 6-carboxy-2′,7′-dichlorodihydrofluorescein diacetate; LDLR, LDL receptor; LXR, liver X receptor; NPC, Niemann-Pick C; TG, triglyceride.
Conflict of interest: D.S. Ory and C.F. Semenkovich have received lecture honoraria
from Merck. C.F. Semenkovich has served as a consultant for Astra-Zeneca, Pfizer,
Bristol-Myers Squibb, and CV Therapeutics and is a founder of Meta Therapeutics.
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To prevent cytotoxicity caused by accumulation of excess cholesterol in macrophages, liver X receptors (LXRs), together with other
members of the nuclear receptor superfamily, contribute to cellular
cholesterol homeostasis by regulating genes that contribute to the
storage, transport, and catabolism of sterols and their metabolites (1).
LXRs respond to elevated cholesterol levels via transactivation
of genes involved in sterol transport, cholesterol efflux and HDL
metabolism, and sterol catabolism (3). Recent studies have shown
that certain oxysterols, such as 27-hydroxycholesterol (27-HC),
are specific ligands for the LXRs (4). 27-HC is enzymatically produced in macrophages in response to cholesterol loading and has
been proposed to be an important physiological LXR ligand (5, 6).
Indeed, fibroblasts from patients with cerebrotendinous xanthomatosis (CTX), a disorder caused by deficiency in sterol 27-hydroxylase and characterized by absence of 27-HC, exhibit altered sterol
regulatory responses (7). CTX is also associated with premature atherosclerosis, although the precise contribution of reduced 27-HC
levels to the atherosclerotic phenotype is unclear because the deficiency in 27-hydroxylation also perturbs bile acid synthesis and
affects multiple metabolic nuclear receptor (e.g., LXR, farnesoid X
receptor, and pregnane X receptor) signaling pathways.
Insight into the mechanisms underlying regulation of cellular
cholesterol homeostasis has come from study of the NPC1 gene.
Fibroblasts from NPC patients exhibit markedly impaired rates of
esterification of LDL-cholesterol (8, 9) and mobilization of newly
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Figure 1
Analysis of BM reconstitution of Ldlr–/– mice after BMT from Ldlr–/–
Npc1+/+ and Ldlr–/–Npc1–/– donors. (A) Transplantation scheme
for generation of Ldlr–/– mice with BM-derived cells deficient in
Npc1. (B) At 6 weeks after BMT, peripheral blood was obtained
from recipients, and cells were stained with anti-CD45.1 and antiCD45.2 to identify Ly5.1- and Ly5.2-positive cells by flow cytometry. Data represent 104 cells from each mouse. (C) Cholesterol
staining of peritoneal macrophages harvested from high-fat fed
MφNpc1+/+ and MφNpc1–/– chimeric mice. Arrowhead denotes
cholesterol-laden lysosomes. Scale bar: 10 μM.

hydrolyzed LDL-cholesterol to the plasma membrane (10–12).
As a consequence of these trafficking defects, NPC mutant fibroblasts demonstrate lysosomal sequestration of LDL-cholesterol,
delayed downregulation of the LDLR, and de novo cholesterol
biosynthesis (13, 14). In NPC1-deficient cells, expression of the
ABCA1 sterol transporter is reduced, resulting in decreased cholesterol efflux (15, 16). Recent studies have shown that the sterol homeostatic defects in NPC disease are caused by failure of
lipoprotein cholesterol both to suppress SREBP-dependent gene
expression and to promote LXR-mediated responses and are associated with impaired LDL-cholesterol–stimulated production of
25-HC and 27-HC (17, 18). Based on these findings, we previously proposed that NPC proteins normally regulate cholesterol
homeostasis by channeling excess LDL-cholesterol to intracellular
sites of oxysterol synthesis, such as the mitochondrial sterol
27-hydroxylase (CYP27A1), resulting in the generation of LDLcholesterol–derived oxysterols (2).
To test whether NPC1-mediated cholesterol trafficking contributes to regulation of macrophage sterol homeostasis in the vessel
wall and modulates susceptibility to atherosclerosis, we examined
the effect of Npc1 deletion in BM-derived cells of chimeric mice on
atherosclerotic lesion development. We showed that macrophage
expression of NPC1 was critical for generation of an endogenous
oxysterol LXR ligand and that NPC1 served an atheroprotective
role through regulation of LXR-dependent cholesterol efflux and
mitigation of cholesterol-induced oxidative stress.
2282
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Results
Generation of mice with deletion of Npc1 in BM-derived cells. We
generated mice with deletion of Npc1 in BM-derived cells
using the BM transplant (BMT) strategy shown in Figure 1A.
Npc1+/– mice (19) were first backcrossed 8 generations into
Ldlr–/– mice, a genetically modified mouse line with increased
susceptibility to atherosclerotic lesion development on a
high-fat diet (20). The Ldlr–/–Npc1+/– mice were intercrossed
with a congenic strain that harbors the Ly5.1 polymorphism
to monitor reconstitution after BMT (21). In the transplanted
mice, the mean reconstitution efficiency was 91.6% at 6 weeks
(n = 122), demonstrating that the hematopoietic lineages were
predominantly derived from the donor BM in the chimeric
mice (Figure 1B). Repopulation with donor-derived macrophages was confirmed in peritoneal macrophages harvested
from chimeric mice reconstituted with Ldlr–/–Npc1–/– macrophages (MφNpc1–/–) by staining for lysosomal accumulation
of free cholesterol (Figure 1C), the hallmark of the NPC1
mutant phenotype (14).
Deletion of Npc1 in BM-derived cells alters serum lipoprotein levels.
To determine the effect of loss of NPC1 expression on atherosclerotic lesion development, transplanted mice were
maintained on a high-fat diet (0.15% cholesterol and 42% fat),
which has previously been shown to promote lesion formation in
Ldlr–/– mice (22), and euthanized after 10 weeks. Serum lipid levels
were measured after 0, 3, 6, and 10 weeks of high-fat diet feeding,
revealing significantly lower cholesterol and triglyceride (TG) levels at 6 and 10 weeks in the chimeric MφNpc1–/– mice compared
Table 1
Lipoprotein analysis of pooled plasma
MφNpc1+/+
Cholesterol (mg/dl)
Total
VLDL
LDL
HDL
TGs (mg/dl)
Total
VLDL
LDL
HDL

1,571 ± 28
854 ± 46
554 ± 32
119 ± 1.0
256 ± 16
145 ± 3.2
51 ± 3.8
10.0 ± 0.47

MφNpc1–/–
961 ± 29A
486 ± 33A
362 ± 14A
91 ± 1.7A
103 ± 4.6A
56.8 ± 0.93A
23.8 ± 1.5A
4.58 ± 0.57A

MφNpc1+/+ and MφNpc1–/– mice were fed high-fat diet for 10 weeks.
Sera from 5–6 animals per genotype were pooled and separated by
FPLC, and individual fractions were assayed for cholesterol and TG
content. Data are mean ± SEM of triplicate determinations for each
genotype. AP ≤ 0.005 versus MφNpc1+/+.
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Figure 2
Serum lipoprotein cholesterol and TG levels in
MφNpc1+/+ and MφNpc1–/– mice fed an atherogenic
diet. (A) Quantitative lipoprotein analysis of serum
lipoproteins. Sera from 9–10 animals per genotype
fed the high-fat diet for 0, 3, 6, and 10 weeks were
pooled and analyzed by HPLC. Data are mean ± SEM.
*P ≤ 0.05, **P ≤ 0.005 versus MφNpc1+/+. (B) FPLC
profile of cholesterol and TGs in mice fed the high-fat
diet for 10 weeks. Sera from 5–6 animals per genotype were pooled and separated by FPLC, and individual fractions were assayed for cholesterol and TG
content. Data represent means of triplicate determinations for each genotype. SEM and statistical analyses
are shown in Table 1.

with MφNpc1+/+ mice (Figure 2A). Pooled serum lipoprotein profiles obtained from chimeric mice after 10 weeks on the high-fat
diet demonstrated significant reductions in both cholesterol and
TGs in the VLDL, LDL, and HDL fractions of MφNpc1–/– compared
with MφNpc1+/+ mice (Figure 2B and Table 1). The lower serum
lipoprotein levels in the MφNpc1–/– mice were not explained by
differences in chow intake (data not shown), body weight (Figure
3A), fractional cholesterol absorption (MφNpc1+/+, 80.1% ± 0.62%;
MφNpc1–/–, 82.8% ± 2.2%; P = NS), or rate of VLDL synthesis (Figure 3B). On the other hand, 125I-VLDL clearance was significantly
accelerated in MφNpc1–/– mice compared with MφNpc1+/+ mice
(Figure 3C) and was accompanied by a hepatic free cholesterol
level 1.8-fold that of MφNpc1+/+ mice (Figure 3D). Examination
of Kupffer cells, BM-derived cells of macrophage lineage located
in the lumen of hepatic sinusoids, revealed free cholesterol levels
1.8-fold and cholesterol ester levels 1.9-fold those of MφNpc1+/+ mice
(Figure 3E), consistent with the NPC phenotype. Because Kupffer
cells represent about 10% of the total hepatic cell population, it is
likely that the bulk of the cholesterol is present in hepatocytes and
accumulates as a result of increased lipoprotein clearance.
Increased aortic atherosclerosis in high-fat diet–fed MφNpc1–/– mice.
Despite lower serum lipids, aortic atherosclerosis was accelerated
in the MφNpc1–/– mice after 10 weeks on the high-fat diet compared
with MφNpc1+/+ mice (Figure 4, A and B). There was no evidence for
a gene dosage effect with respect to susceptibility to atherosclerosis, because MφNpc1+/– and MφNpc1+/+ mice exhibited nearly identical levels of aortic atherosclerosis. Aortic sinus sections in the
MφNpc1–/– mice demonstrated markedly increased Oil red O staining for neutral lipid accumulation (Figure 4C). The aortic lesions
in both MφNpc1+/+ and MφNpc1–/– mice exhibited a high degree
The Journal of Clinical Investigation

of cellularity with extensive macrophage infiltration, in agreement with an earlier report (23), and no changes were observed in
the extent of macrophage apoptosis (data not shown). However,
MφNpc1–/– mice did not exhibit the profound atherothrombotic
phenotype previously observed in the whole-body Npc1–/–Apoe–/–
mice (23). The discordance between the serum lipoprotein levels
and aortic atherosclerosis suggested that intrinsic alterations in
macrophage sterol metabolism in the MφNpc1–/– mice likely play
a greater role in atherosclerotic lesion formation than do serum
lipoprotein levels. Previous studies have shown that NPC1 mutant
fibroblasts fail to induce ABCA1 mRNA and protein expression
in response to cholesterol loading (16, 24) and exhibit impaired
ABCA1-mediated cholesterol efflux to apoA-I (15). To investigate
whether a defect in activation of the LXR pathway in the Npc1–/–
macrophages contributed to the accelerated atherosclerosis in the
MφNpc1–/– mice, we examined Abca1 and Abcg1 gene expression in
peritoneal macrophages harvested from the chimeric mice. We
found that lipoprotein-stimulated Abca1 and Abcg1 mRNA expression was reduced by 49% and 57%, respectively, in macrophages
from MφNpc1–/– mice (Figure 5A). Consistent with these findings,
cholesterol efflux to apoA-I and HDL (extracellular acceptors for
ABCA1- and ABCG1-mediated cholesterol transport, respectively)
was reduced by 55% and 46% at 4 hours and by 26% and 33% at 24
hours, respectively (Figure 5, B and C). Treatment of Npc1–/– macrophages with T0901317, a synthetic LXR ligand, led to significant
increases in cholesterol efflux to both apoA-I and HDL. Indeed,
incubation of Npc1–/– macrophages with T0901317 corrected the
defect in cholesterol efflux to apoA-I (WT, 19.6% ± 0.94%; Npc1–/–
plus T0901317, 20.8% ± 0.17%; P = NS), suggesting that activation with the synthetic ligand is able to bypass, at least in part,
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Figure 3
Lipoprotein metabolism studies in MφNpc1+/+ and
MφNpc1–/– mice fed an atherogenic diet for 10
weeks. (A) Body weight. (B) TG production. Fasting TG levels were determined at time 0. Mice were
injected with Triton WR 1339 to inhibit systemic
lipolysis or with PBS control, and venipuncture was
performed at 30, 60, and 120 minutes. (C) VLDL
clearance. Mice were injected with 125I-VLDL, and
blood was collected 0–240 minutes after injection.
The amount of 125I-VLDL remaining in plasma
at each time point was expressed as a percentage relative to the 125I-radioactivity in the plasma
1 minute after initial injection. (D) Liver tissue cholesterol content (n = 8–9 per genotype). (E) Cholesterol content of Kupffer cell fractions isolated
from the liver. Fractions from 2 mice per genotype
were pooled, lipids were extracted, and cholesterol
was measured by GC/MS. FC, free cholesterol;
CE, cholesterol ester. For all experiments shown,
data are mean ± SEM of triplicate determinations
and are representative of 2 independent experiments. *P < 0.05 versus MφNpc1+/+.

the block imposed by NPC1 loss of function. Taken together, our
findings show that failure to activate LXR-mediated responses in
macrophages from MφNpc1–/– mice may have contributed to atherosclerotic lesion formation.
LXR ligand deficiency in macrophages from MφNpc1–/– mice. Previously we showed that the sterol homeostatic defects in NPC1
mutant cells were associated with a profound decrease in synthesis
of LDL-cholesterol–derived oxysterols (17, 18). To assess whether
decreased production of 27-HC, an endogenous LXR ligand,
causes reduced LXR-mediated cholesterol efflux, we measured
oxysterol production in peritoneal macrophages in response to
acetylated LDL (AcLDL) cholesterol loading. While mRNA levels
of CYP27A1, the mitochondrial sterol 27-hydroxylase responsible
for conversion of cholesterol to 27-HC, were equivalent in macrophages isolated from MφNpc1+/+ and MφNpc1–/– mice (data not
shown), synthesis of 27-HC and its oxidation product, cholestenoic acid, were reduced in Npc1–/– macrophages by 52% and 64%,
respectively (P < 0.05; Figure 6A). Similar reductions in 27-HC syn2284
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thesis were observed in non–lipoprotein-fed Npc1–/– macrophages
(data not shown), indicating that lipoprotein-associated oxysterols did not substantially contribute to 27-HC levels. Moreover, in
the plasma of high-fat diet–fed MφNpc1–/– mice, total 27-HC levels were reduced by 43% (MφNpc1+/+, 541 ± 2.5 ng/ml; MφNpc1–/–,
310 ± 0.34 ng/ml; P < 0.05), and free 27-HC levels were reduced
by 24% (MφNpc1+/+, 145 ± 5.5 ng/ml; MφNpc1–/–, 111 ± 2.4 ng/ml;
P < 0.05; Figure 6B). Total plasma 27-HC is representative of the
vast majority of 27-HC that is esterified and lipoprotein associated, whereas free 27-HC is more representative of the non–lipoprotein-associated 27-HC (25, 26). In light of the rapid hepatic
uptake of free 27-HC, the reduced circulating levels of free 27-HC
in MφNpc1–/– mice likely reflect lower rates of 27-HC synthesis by
tissue macrophages, the principal source of circulating 27-HC
(27), and not simply lower serum lipoprotein levels.
Increased oxidative stress in Npc1–/– macrophages. In addition to the
deficiency in enzymatic synthesis of 27-HC, Npc1–/– mouse tissues
exhibit increased nonenzymatic oxidation (i.e., autoxidation) of cel-
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Figure 4
Aortic atherosclerosis in MφNpc1+/+ and MφNpc1–/– mice
after 10 weeks on a high-fat diet. (A) En face images of representative aortas. Arrows denote atherosclerotic plaque.
(B) Quantification of aortic intimal lesions. For each aorta,
separate measurements of lesion area were performed in
the arch, thoracic aorta, and abdominal aorta. Combined
lesion area was significantly greater in MφNpc1–/– than in
MφNpc1+/+ mice (P < 0.05). (C) Atherosclerosis at aortic
origin. Frozen aortic cross-sections from representative
high-fat diet–fed MφNpc1+/+ and MφNpc1–/– chimeric mice
were stained with hematoxylin and Oil red O. Arrows indicate regions staining for Oil red O. Original magnification,
×10 (A); ×100 (C).

lular cholesterol, resulting in a several-fold increase in total cholesterol oxidation products (28). Autoxidation products, which include
steroid ring–modified 5,6- and 7-oxygenated compounds (29), have
been reported to be cytotoxic in vitro and proposed to contribute
to atherogenesis (30). We therefore monitored for the presence
of the cholesterol oxidation products in the plasma of MφNpc1+/+
and MφNpc1–/– mice and in conditioned media and cell extracts
of lipoprotein-fed peritoneal macrophages harvested from the
chimeric mice. Total cholesten-3β,5α,6β-triol (an oxidation product of both 5α,6α-epoxycholesterol and 5β,6β-epoxycholesterol),
7β-HC, and 7-ketocholesterol levels in plasma from MφNpc1–/– mice
were respectively 3.7-, 2.2-, and 1.15-fold those of MφNpc1+/+ mice
(P < 0.05; Figure 7A). Levels of cell-associated oxysterols in MφNpc1–/–
macrophages were uniformly elevated for all oxysterols examined
(Figure 7B), even among enzymatically generated side-chain oxysterols 24-HC, 25-HC, and 27-HC, for which total oxysterol synthesis (media plus cell-associated oxysterols) was reduced (Figure
6A). For the oxysterol panel measured in the cell extracts, total cellular oxysterols were 3.67 μg/mg protein in Npc1–/– macrophages,
compared with 1.42 μg/mg protein in MφNpc1+/+ macrophages,
consistent with the oxysterol accumulation previously reported in
Npc1–/– murine tissues (28). The intracellular accumulation of oxysterols may reflect impaired oxysterol efflux due to reduced expression of LXR-activated sterol transporters. Recent reports showing
that 7-ketocholesterol, 25-HC, and 27-HC accumulate in ABCG1-,
ABCA1-, and ABCG1/ABCG4-deficient cells, respectively, support
such a mechanism (31–33). Whether the elevated levels of nonenzymatic cholesterol autoxidation products, which have been shown to
be cytotoxic in vitro, also contribute to atherogenesis in vivo, or are
simply markers of oxidative stress, is not known.
Cholesterol autoxidation products are formed through the
interaction of cholesterol with ROS (34). To determine whether
The Journal of Clinical Investigation

increased ROS generation is responsible for the elevated oxysterol
levels in the Npc1–/– macrophages, we measured cell fluorescence
following loading with 6-carboxy-2′,7′-dichlorodihydrofluorescein
diacetate (H2DCFDA), a fluorescent, membrane-permeable probe
widely used as a marker of ROS in cells (35). We found increased
ROS generation in the MφNpc1–/– macrophages, 2.2-fold that of
MφNpc1+/+ macrophages, indicative of increased cellular oxidative
stress (Figure 7C). Protein carbonyl levels, a marker of cumulative oxidative stress, were nearly 2-fold those of MφNpc1+/+ macrophages, providing further support for increased ROS generation in
MφNpc1–/– cells (Figure 7D). Treatment with T0901317, a synthetic oxysterol LXR ligand previously shown to upregulate ABCA1
expression and cholesterol efflux in Npc1–/– fibroblasts (24, 36),
reduced ROS accumulation by 38%, partially suppressing oxidative stress in the MφNpc1–/– macrophages (Figure 7C).
Discussion
In this study we investigated the role of NPC1-mediated cholesterol trafficking in regulation of macrophage cholesterol homeostasis. Using BMT to disrupt NPC1 expression in macrophages of
Ldlr–/– mice, we demonstrated that absence of NPC1 expression was
proatherogenic in vivo. Deletion of Npc1 in BM-derived cells accelerated atherosclerosis by impairing cholesterol efflux and promoting cellular oxidative stress. The Npc1–/– chimeric mice exhibited
increased atherosclerotic lesion formation despite lower cholesterol
and TG levels in the VLDL and LDL fractions. The discordance
observed between serum cholesterol and the extent of atherosclerosis underscores the central role of the NPC cholesterol trafficking
pathway in regulation of macrophage lipid metabolism and modulating the susceptibility of these cells to oxidative stress.
Previous studies have shown that Npc1–/– cells in culture have
impaired cholesterol efflux. The lysosomal sequestration of LDL-
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Figure 5
Reduced expression of cholesterol transporters and
cholesterol efflux in MφNpc1–/– chimeric mice. (A)
Abca1 and Abcg1 gene expression in peritoneal macrophages harvested from high-fat diet–fed MφNpc1+/+ and
MφNpc1–/– mice. Expression was determined by realtime quantitative RT-PCR and normalized to expression
in MφNpc1+/+ macrophages. (B and C) Cholesterol efflux
to apoA-I and HDL from peritoneal macrophages harvested from high-fat diet–fed MφNpc1+/+ and MφNpc1–/–
mice. Cells were incubated overnight with AcLDL
labeled with [3H]cholesterol, followed by incubation for
4 (B) or 24 hours (C) in medium containing 0.2% BSA
with 10 μg/ml human apoA-I or 50 μg/ml human HDL.
ApoA-I– or HDL-specific cholesterol efflux is shown as
the radioactivity released from the cells into the medium,
expressed as a percentage relative to the total radioactivity in cells and media. T/9-cis RA, T0901317. Data
are mean ± SEM of triplicate determinations and are
representative of 2 independent experiments. *P ≤ 0.05,
**P ≤ 0.01 versus respective MφNpc1+/+; #P ≤ 0.05,
##P ≤ 0.01 versus respective untreated MφNpc1 –/–;
†P = NS versus untreated ApoA-I MφNpc1+/+.

derived cholesterol affects efflux activity by limiting cholesterol
substrate for ABCA1-dependent efflux and by failing to appropriately generate LDL-cholesterol–derived side-chain oxysterols (15,
17, 18). In Npc1–/– cells, decreased production of side-chain oxysterols, which serve as endogenous LXR ligands, results in reduced
ABCA1 protein expression and lower cholesterol efflux activity (16,
24). Thus, in cultured cells NPC1-mediated cholesterol trafficking
participates in regulation of LXR sterol homeostatic responses. In
the present study, we provide evidence that the NPC1 cholesterol
trafficking pathway regulates LXR-dependent cholesterol efflux in
vivo, alleviating cholesterol-induced oxidative stress and serving an
atheroprotective role.

While the function of NPC1 in distribution of free cholesterol from
the late endocytic pathway is well characterized, little is known of the
macrophage-specific role of NPC1 in regulating sterol homeostasis
in vivo and in modulating susceptibility to atherosclerosis. A previous study that examined the effect of Npc1 deficiency on atherogenesis did not find differences in aortic lesional area in high-fat diet–fed
Npc1+/–Apoe–/– mice compared with Apoe–/– mice, although NPC1
heterozygosity was associated with resistance to lesional necrosis
and lesional macrophage apoptosis (37). More recently, Welch et al.
reported that introduction of the Npc1–/– mutation into the Apoe–/–
background predisposed to increased lesion formation and atherothrombosis (23). In agreement with these studies, we found that NPC1

Figure 6
Npc1–/– macrophages are deficient in production of endogenous oxysterol ligands. (A) Production of 27-HC and
cholestenoic acid in macrophages harvested from high-fat
diet–fed MφNpc1+/+ and MφNpc1–/– chimeric mice. Macrophages were cultured in lipoprotein-deficient medium followed by overnight incubation with 50 μg/ml AcLDL. Lipids
were extracted from media, and cells and oxysterols were
measured by GC/MS. Data are mean ± SEM and are representative of 2 independent experiments. (B) Plasma oxysterol levels in high-fat diet–fed MφNpc1+/+ and MφNpc1–/–
chimeric mice. Sera from 5–6 animals per genotype were
pooled and analyzed by GC/MS. Data are mean ± SEM of
triplicate determinations and are representative of 2 independent experiments. *P < 0.05 versus MφNpc1+/+.
2286
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Figure 7
Oxidative stress in high-fat diet–fed MφNpc1+/+
and MφNpc1–/– mice. (A) Plasma levels of cholesterol autoxidation products. Sera from 5–6
animals per genotype were pooled and analyzed
by GC/MS. Data are mean ± SEM for triplicate
measurements and are representative of 2 independent experiments. (B) Levels of cell-associated oxysterols in harvested macrophages. Lipids
were extracted from cells, and oxysterols were
measured by GC/MS. Data are mean ± SEM for
triplicate measurements and are representative
of 2 independent experiments. (C) Measurement
of ROS in harvested macrophages. Macrophages
were cultured overnight in lipoprotein-deficient
serum (LPDS) in the presence or absence of
10 μM T0901317 and incubated for 30 minutes
with 10 μM H2DCFDA, after which fluorescence
was determined. Data are mean ± SEM for triplicate measurements and are representative of
2 independent experiments. (D) Oxidative damage in harvested macrophages was assessed by
measuring protein carbonylation in cell lysates.
Ponceau S staining served as a loading control.
Data are mean ± SEM and are representative of
2 independent experiments. *P < 0.05, **P < 0.01
versus respective MφNpc1+/+.

loss of function, but not NPC1 haploinsufficiency, promoted aortic
atherosclerosis in mice fed the high-fat diet. We further extended
these earlier reports by demonstrating the selective role of Npc1–/–
BM-derived cells to the proatherosclerotic phenotype and by elucidating the contribution of the NPC cholesterol trafficking pathway
in vivo to LXR-dependent cholesterol efflux in macrophages. Given
the high level of NPC1 expression in the monocyte/macrophage lineage and the importance of these cells to lipoprotein metabolism, it
is probable that deletion of Npc1 in macrophages is primarily responsible for the accelerated atherosclerosis, although the contribution
of non-macrophage BM-derived cells cannot be excluded. Because
complete disruption of NPC1 expression is required to increase susceptibility to atherosclerosis, we conclude that the protective effect of
NPC1-mediated cholesterol trafficking is not gene dose dependent.
We propose that decreased mitochondrial conversion of lipoprotein cholesterol to 27-HC in the Npc1–/– macrophages is
the principal mechanism for accelerated atherosclerosis in the
MφNpc1–/– model. Decreased 27-HC levels, which have been
reported previously in other Npc1–/– cell types (17, 18), may reflect
impaired delivery of cholesterol substrate to the inner mitochondrial membrane for side-chain oxysterol synthesis. However, recent
reports showing that mitochondrial membranes in Npc1–/– cells
are enriched in cholesterol (38, 39) indicate that the consequence
of NPC1 loss of function may be more complex than failure of
bulk cholesterol delivery to the mitochondria. Despite the endosomal cholesterol trafficking defect, cholesterol transport to mitochondria is enhanced in Npc1–/– cells, leading to inhibition of ATP
synthase activity (38). Free cholesterol loading of the mitochondria could prevent transfer of cholesterol from the outer to inner
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mitochondrial membranes, where oxysterol synthesis occurs, or
could inhibit sterol 27-hydroxylase enzymatic activity directly. It is
likely that the lower 27-HC levels observed in Npc1–/– macrophages
result from decreased oxysterol synthesis rather than enhanced
catabolism of 27-HC, because we did not observe a commensurate increase in the levels of known oxidation products of 27-HC,
such as cholestenoic acid (Figure 6A), or of 7α,27-HC or 7β,27-HC
(ref. 40 and data not shown). In Npc1–/– macrophages, deficiency
of 27-HC, which is known to activate LXR gene expression and has
been proposed as an endogenous LXR ligand (4–6), is associated
with decreased expression of the ABCA1 and ABCG1 sterol transporters, impaired cholesterol efflux, and lower serum HDL levels.
Therefore, in the Npc1–/– macrophages, we conclude that 27-HC
deficiency is responsible for decreased LXR activation and contributes to atherosclerotic lesion formation by failing to stimulate cellular cholesterol efflux. To the best of our knowledge, our findings
are the first to implicate deficiency of an endogenous LXR ligand
in vivo in the development of atherosclerosis.
Our findings support a central role for NPC1 in macrophage
reverse cholesterol transport. By directing a portion of the lipoprotein-derived cholesterol to sites of oxysterol synthesis, the NPC
pathway is responsible for generation of endogenous LXR ligands
that govern expression of the ABCA1 and ABCG1 cell surface sterol
transporters. In macrophages, ABCA1 and ABCG1 act in concert to
facilitate to reverse cholesterol transport initially through lipidation of nascent apoA-I, followed by its subsequent remodeling into
mature, spheroidal HDL (41). In previous BMT studies, combined
deletion of ABCA1 and ABCG1 led to a massive lipid accumulation in macrophages that was far more dramatic than occurred
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with deletion of either ABCA1 or ABCG1 alone (42–46). Thus, the
profound atherosclerotic phenotype in the mice with deletion of
Npc1 in BM-derived cells appears to reflect the upstream role of the
NPC cholesterol trafficking pathway for induction of these LXRactivated sterol transporters.
Increased oxidative stress in the Npc1–/– macrophages may also
have contributed to atherosclerotic lesion formation in vivo. The
etiology of elevated ROS generation and oxidative damage in the
Npc1–/– macrophages does not appear to relate to ER stress, because
no increase was found in expression of ER stress markers grp78,
calreticulin, or CCAAT/enhancer-binding protein homologous
protein (CHOP) (data not shown). Rather, increased ROS may be a
consequence of free cholesterol–mediated mitochondrial dysfunction. In addition to inhibition of ATP synthase activity and loss of
membrane potential, cholesterol accumulation in mitochondrial
membranes is associated with mitochondrial glutathione depletion, which sensitizes cells to oxidative stress (38, 39). ROS generated by oxidative stress are a well-established signal for activation
of NF-κB, a key transcription factor in the induction of inflammatory mediators (47). Thus, induction of NF-κB–dependent pathways, possibly involving lipoprotein oxidation and inflammatory
cell recruitment, may have accelerated atherosclerosis in the chimeric MφNpc1–/– model (48).
Under conditions of cholesterol excess, the mitochondria
likely serve as an important link between LXR-dependent pathways and modulation of oxidative stress in macrophages. In
Npc1–/– macrophages, decreased oxysterol synthesis by the mitochondrial sterol 27-hydroxylase resulted in failure to activate
LXR-dependent gene expression and cholesterol efflux, further
exacerbating free cholesterol–induced mitochondrial dysfunction and promoting oxidative stress. The accumulation of cholesterol autoxidation products in the Npc1–/– macrophages may
be caused not only by the highly oxidative intracellular milieu,
but also by decreased oxysterol export by the LXR-regulated
ABCA1 sterol transporter (31). An unexpected finding in our
study was that treatment with the synthetic LXR ligand attenuated ROS generation. These results suggest that pharmacological activation of LXR pathways in macrophages provides
atheroprotection both by lowering cellular cholesterol and by
suppressing mitochondria-mediated oxidative stress.
Because human NPC1 disease is a rare disorder that is generally fatal in the first 2 decades of life, the incidence of atherosclerotic disease in affected individuals or in obligate heterozygotes is
not known. Given the pathophysiological effects of disruption of
NPC1 function in macrophages, we speculate that polymorphisms
in the NPC1 gene may modulate atherosclerosis susceptibility. In
light of our findings that plasma 27-HC levels correlated with
impaired 27-HC synthesis in the cultured macrophages, detection of altered circulating levels of this proposed physiological
LXR ligand (5, 6) may provide important insight into cholesterol
metabolism in the vessel wall. In particular, plasma levels of 27-HC
and other oxysterol species potentially could serve as novel biomarkers to facilitate early detection and stratification of human
subjects at risk for atherosclerotic disease.
Methods
Mice. BALB/c Npcnih mice were obtained from The Jackson Laboratory,
backcrossed 8 generations into the C57BL/6 background, and then intercrossed with C57BL/6 Ldlr–/– Ly 5.1 mice to generate BMT donors with the
following genotypes: Npc1–/–Ldlr–/– Ly5.1, Npc1+/–Ldlr–/– Ly5.1, and Npc1+/+
2288
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Ldlr–/– Ly5.1. Experimental procedures were approved by the Washington
University Animal Studies Committee and were conducted in accordance
with the USDA Animal Welfare Act and the Public Health Service Policy for
the Humane Care and Use of Laboratory Animals.
BMT. BM was harvested from sex-matched Npc1–/–Ldlr–/– Ly5.1, Npc1+/–
Ldlr–/– Ly5.1, and Npc1+/+Ldlr–/– Ly5.1 donors by flushing the femurs and
tibias with PBS. Male C57BL/6 Ldlr–/– Ly5.2 recipients (4–6 weeks old)
were lethally irradiated with 10 Gy from a 137Cs source, followed by tail
vein injection with 106 BM cells. Prophylactic antibiotics (sulfamethoxazole and trimethoprim) were administered for 2 weeks after BMT. At
6 weeks after BMT, peripheral blood was obtained from recipients, and
cells were stained with anti-CD45.1 and anti-CD45.2 to identify Ly5.1and Ly5.2-positive cells by flow cytometry, as previously described (21), to
evaluate the reconstitution.
High-fat diet feeding. Transplanted mice with greater than 75% reconstitution were placed on a high-fat diet containing 0.15% cholesterol and
providing 42% calories as fat (TD 88137; Harlan Teklad). Serum cholesterol and TG measurements were performed at 0, 3, 6, and 10 weeks after
initiation of high-fat diet feeding. Mice were fasted for 4 hours prior to
blood draws. Sera of mice fed the high-fat diet for 10 weeks were pooled to
obtain lipoprotein profile by fast protein liquid chromatography (FPLC)
(49). High-sensitivity lipoprotein profiling was performed using the LipoSEARCH method by Skylight Biotech Inc. (50).
Atherosclerotic lesion quantification. Lesion area was determined as described
previously (51). Digital images of pinned aortas were analyzed using an
image-processing program. Lesional areas were determined as the percentage of involvement of the intimal surface area for the arch (extending from
the aortic valve to a point just distal to the left subclavian artery), the thoracic aorta (extending to the last intercostal artery), and the abdominal
aorta (extending to the ileal bifurcation).
Immunocytochemistry. Hearts were frozen in Tissue-Tek OCT compound,
and sections were obtained through the aorta root. Frozen sections
were fixed with acetone, and immunohistochemistry was performed as
described previously (49). Sections were stained with Oil red O and Mac-3
to detect neutral lipids and macrophages, respectively. Cholesterol staining
of peritoneal macrophages was performed using BC-Θ, a FITC-conjugated
derivative of perfingolysin O (Θ toxin) (52).
Lipoprotein metabolism. VLDL clearance was performed as described previously (53). Briefly, VLDL was obtained from pooled donor Ldlr–/– mice
and labeled with 125I to produce 125I-VLDL. Unincorporated 125NaI was
removed with PD-10 columns, and FPLC was used to isolate the VLDLspecific fraction. Mice were anesthetized and injected with a 0.2-ml bolus
of 125I-VLDL, and blood was subsequently collected at regular intervals.
Data at each time point are presented as the mean from at least 3 different
animals. VLDL synthesis rates were determined by inhibiting intravascular
lipolysis with Triton WR 1339 (54). After measurement of baseline TGs,
fasted mice were injected with WR 1339 (60 mg/kg) or PBS, and serum TGs
were determined at 30, 60, and 120 minutes.
Cholesterol absorption assay. For cholesterol absorption studies, mice
were maintained on sterol-deficient chow diet for 2 days before gavage
with 0.1 ml soybean oil containing 0.0625 mg d4-sitostanol and 0.25 mg
d7-cholesterol. Feces were collected for 3 days. Sterols were purified from
feces and measured by gas chromatography/mass spectrometry (GC/MS)
as described previously (55). The percent of d7-cholesterol in the stool
was calculated from each tracer recovered relative to the respective total
amount administered.
Kupffer cell isolation. Kupffer cells were isolated from liver tissue using a
2-step collagenase-dispase perfusion method as previously described (56).
Real-time quantitative RT-PCR. RNA isolation, cDNA synthesis, and realtime PCR using SYBR Green Master Mix with template-specific primers
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was performed as described previously (24). Fold changes in gene expression were determined by normalization to 36B4 expression.
Cholesterol efflux assay. Thioglycollate-elicited peritoneal macrophages
were harvested as described previously (57). Macrophages were incubated
with [3H]cholesterol-labeled AcLDL, followed by incubation for 4 hours in
medium containing 0.2% BSA and 10 μg/ml human apoA-I or 50 mg/ml
human HDL. ApoA-I– and HDL-specific cholesterol efflux were calculated
as the radioactivity released from the cells into the medium, expressed as a
percentage relative to total radioactivity in cells and media.
Oxysterol determinations. Thioglycollate-elicited peritoneal macrophages
were harvested as described above. Macrophages were grown in DMEM
plus 10% FBS for 4 hours and then changed to DMEM with 10% lipoprotein-deficient serum. Macrophages were refed DMEM with 10% lipoprotein-deficient medium containing 50 μg/ml AcLDL overnight, followed by
harvest of medium and cells for lipid extraction. Oxysterols were extracted
from the media and measured by GC/MS as previously described using 200
pmol deuterated 27-HC (d5–27-HC) as an internal standard (17). Quantitative GC/MS determinations for oxysterol species were calculated from triplicate injections. Total cellular proteins were extracted with 0.1 N NaOH
and quantified using the BCA assay, and oxysterol measurements were normalized to the total protein values. For serum oxysterol measurements,
pooled sera of 5–6 animals per genotype were divided into 2 250-μl fractions and analyzed by GC/MS. The free and total samples were processed
identically, except that the total samples underwent saponification (1 hour
at room temperature) prior to oxysterol isolation to hydrolyze sterol esters
(58). Oxysterol determinations were performed as described above.
Detection of ROS. Cellular levels of ROS were determined as previously
described (35). Peritoneal macrophages were harvested as described previously (57) and plated in DMEM plus 10% FBS. Cells were washed in
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